ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
71 hedge funds and large institutions have $86.1M invested in Endocyte, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less call options, than puts
Call options by funds: $737K | Put options by funds: $1.79M
Holders
71
Holding in Top 10
–
Calls
$737K
Puts
$1.79M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$14.4M | |
| 3 | +$7.11M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.21M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.65M |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$547K | |
| 3 | -$510K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$353K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
-$348K |